For whom the bell tolls: Susceptibility to common adult cancers in retinoblastoma survivors

Journal of the National Cancer Institute

Volumn 96, Issue 5, 2004, Pages 342-343

  Kay, Frederic J ^a   Harbour, J William ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; RETINOBLASTOMA PROTEIN;

ADULT; BLADDER CANCER; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CLONING; EDITORIAL; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; GERM LINE; HETEROZYGOTE; HUMAN; LONG TERM EXPOSURE; LUNG CANCER; PRIORITY JOURNAL; RETINOBLASTOMA; TOBACCO; TUMOR SUPPRESSOR GENE; ALLELE; DISEASE PREDISPOSITION; GENETICS; INCIDENCE; LUNG TUMOR; METHODOLOGY; MORTALITY; MOSAICISM; MUTATION; NOTE; RADIOTHERAPY; RETINA TUMOR; RETROSPECTIVE STUDY; SECOND CANCER; SMALL CELL CARCINOMA; SURVIVOR;

ADULT; ALLELES; CARCINOMA, SMALL CELL; DISEASE SUSCEPTIBILITY; HUMANS; INCIDENCE; LUNG NEOPLASMS; MOSAICISM; MUTATION; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; SURVIVORS;

EID: 1542499463     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh080     Document Type: Editorial

References (16)

1. DeVita VT Jr. Hodgkins's disease - clinical trials and travails [published erratum appears in N Engl J Med 2003;349:202]. N Engl J Med 2003;348: 2375-6.
2. Abramson DH. Second nonocular cancers in retinoblastoma: A unified hypothesis. The Franceschetti Lecture. Ophthalmic Genet 1999;20:193-204.
3. Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997;278:1262-7.
4. Lohmann DR, Gerick M, Brandt B, Oelschlager U, Lorenz B, Passarge E, et al. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. Am J Hum Genet 1997;61:282-94.
5. Klutz M, Horsthemke B, Lohmann DR. RB1 gene mutations in peripheral blood DNA of patients with isolated unilateral retinoblastoma. Am J Hum Genet 1999;64:667-8.
6. Otterson GA, Modi S, Nguyen K, Coxon AB, Kaye FJ. Temperature-sensitive RB mutations linked to incomplete penetrance of familial retinoblastoma in 12 families. Am J Hum Genet 1999;65:1040-6.
7. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988;241:353-7.
8. Kaye FJ. RB and cyclin dependent kinase pathways: Defining a distinction between RB and p16 loss in lung cancer. Oncogene 2002;21:6908-14.
9. Abramson DH, Ellsworth RM, Kitchin FD, Tung G. Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology 1984;91:1351-5.
10. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 1986;53:661-71.
11. Lueder GT, Judisch F, O'Gorman TW. Second nonocular tumors in survivors of heritable retinoblastoma. Arch Ophthalmol 1986;104:372-3.
12. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology 1988;95:1583-7.
13. Moll AC, Kuik DJ, Bouter LM, Den Otter W, Bezemer PD, Koten JW, et al. Incidence and survival of retinoblastoma in The Netherlands: A register based study 1862-1995. Br J Ophthalmol 1997;81:559-62.
14. Sanders BM, Jay M, Draper GJ, Roberts EM. Non-ocular cancer in relatives of retinoblastoma patients. Br J Cancer 1989;60:358-65.
15. Kleinerman RA, Tarone RE, Abramson DH, Seddon JM, Li FP, Tucker MA. Hereditary retinoblastoma and risk of lung cancer. J Natl Cancer Inst 2000;92:2037-9.
16. Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004;96:357-63.